Clinical Trial Update: Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating an RNActive-derived cancer vaccine with local radiation for stage IV non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RNActive-derived cancer vaccine (RNActive-derived cancer vaccine)

Snippet

Sponsor: CureVac | Conditions: Non-Small Cell Lung Carcinoma | Phase 1 | Status: TERMINATED